Lung ultrasound (LUS) has emerged as a valuable tool in diagnosing pneumonia in children, particularly in settings where traditional imaging methods may be less accessible. This non-invasive ...
In COPD, the lung may express even greater variability, since the airways may be affected even more than the parenchyma. Emphysema is patchy at the same time, while the airways and local areas in ...
Trained health care professionals with AI assistance can achieve images that do not differ from lung ultrasound experts. HealthDay News — Trained health care professionals (THCPs), including medical ...
Nerandomilast is under clinical development by Boehringer Ingelheim International and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, ...
Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan.
Belimumab is under clinical development by GSK and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, Phase III drugs for Interstitial ...
FRIDAY, Jan. 17, 2025 (HealthDay News) -- Trained health care professionals (THCPs), including medical assistants, respiratory therapists, and nurses, with artificial intelligence (AI) assistance can ...
thewomens.org.au Objective Lung ultrasound (LUS) has shown promise as a diagnostic tool for the evaluation of the newborn with respiratory distress. No study has described LUS during ‘normal’ ...
Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help ...